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Background: Nutrient levels are known to influence the development of osteoarthritis (OA), presumably by
modulating levels of matrix biosynthesis and degradation. These processes may be affected by ascorbic acid (AA),
an antioxidant which acts as a cofactor for numerous biochemical reactions and is essential for post-translational
modifications of collagen. In this study we examined the expression of SVCT2, the only known Sodium coupled
vitamin C transporter isoform present in articular cartilage, in human articular cartilage explants derived from both
normal and osteoarthritis articular cartilage.
Methods: OA1 and OA3 human articular cartilage was carefully dissected and macroscopically graded for
degeneration via the Collins scale. The tissue samples were histologically examined by Hematoxylin and Eosin and
Safranin O and Fast Green staining. SVCT2 expression analysis was performed at mRNA level by quantitative real time
PCR and at a protein level by immunohistochemistry.
Results: Our quantitative real time PCR showed marked variation in the expression of SVCT2 in human osteoarthritic
articular cartilage. SVCT2 expression was significantly down-regulated (p = 0.0001) in the Collins grade 3 (OA3)
compared to Collins grade 1 (OA1) tissue. Furthermore, slides stained with fluorescent antibodies to SVCT2
demonstrated greatly reduced fluorescence for the SVCT2 transporter on the chondrocyte plasma membrane in the
osteoarthritic tissue samples.
Conclusions: These findings demonstrate that the expression of SVCT2 transporter is significantly altered in human
osteoarthritic tissues (OA3). The modulation of this transporter could therefore potentially influence the prevention,
management and treatment of osteoarthritis.
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Osteoarthritis (OA) can be defined as a process of aber-
rant repair with gradual and progressive loss of articular
cartilage through degradative mechanisms. Progressive
deterioration of the articular cartilage leads to impaired
joint motion, severe pain, and ultimately, disability. Pri-
marily, the causes of OA are aging, obesity , mechanical* Correspondence: sfulzele@gru.edu
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reproduction in any medium, provided the orstress [1], oxidative stress [2] and altered nutrient levels
[3], all of which have been found to affect matrix com-
position, presumably by modulating rates of macromol-
ecular biosynthesis and degradation. These processes
may be modulated in part by the micronutrient ascorbic
acid (vitamin C or AA), which is essential for normal
collagen synthesis through its role in the post-translational
modification of collagen. These post-translation processes
include the hydroxylation of proline and lysine both of
which are critical for the maintence of connective tissue
integrity [4]. Additionally, vitamin C is the primary water-
soluble antioxidant, serving as a powerful scavenger of re-
active oxygen and nitrogen species. It is therefore clearlyral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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essential for the normal function of articular cartilage.
Since adult cartilage contains no vasculature supply,
chondrocytes metabolize largely anaerobically, obtaining
their nutrition via the synovial fluid by means of diffu-
sion [5]. However, since ascorbic acid is highly water-
soluble, it cannot simply diffuse across the hydrophobic
lipid bilayer of the plasma membrane to gain access into
these cells; specific transport systems must exist in the
plasma membrane to mediate the entry process. Two
isoforms of the sodium-dependent vitamin C trans-
porters (SVCT1 and SVCT2) are expressed in many
human and mouse tissues but only SVCT2 is expressed
in articular cartilage [6,7]. Additionally, it has been also
reported that aging, oxidative stress, and inflammatory
factors regulate SVCT2 expression in various mammalian
tissues, and the same factors also contribute to osteoarth-
ritis. Therefore, it is important to collect fundamental in-
formation regarding changes in the expression of SVCT2
in osteoarthritis. We hypothesize that the SVCT2 trans-
porter plays a key role in the normal function of articular
chondrocytes, and that alteration in SVCT2 expression
may contribute to cartilage degeneration. Alterations in
the expression of the SVCT2 transporter have not yet
been studied extensively in the osteoarthritic human
tissues.
The present study examined the expression of SVCT2
in human articular chondrocytes derived from osteoarth-
ritis grade 1 (OA1) and osteoarthritis grade 3 (OA3) at
mRNA level by quantitative real time PCR and at pro-
tein level by immunohistochemistry. Our findings dem-
onstrate that when normal human articular cartilage is
compared to osteoarthritic tissue, notable changes in the
distribution and expression of SVCT2 are seen. The
modulation of this transporter could therefore potentially




Osteoarthritis grade 1 (OA1) and Osteoarthritis grade 3
(OA3) human cartilage was obtained from distal, anter-
ior, and posterior femoral cuts from the knee joints of
29 tissue donors (13 males and 16 females) undergoing
total knee arthroplasty procedures. All studies were per-
formed with approval from the Georgia Health Sciences
University Institutional Review Board (IRB) and written
informed consent was obtained from all participants for
the publication of individual data and accompanying
clinical images. The cartilage tissue was obtained from
the operating room at the time of surgery, transported
to the laboratory, washed with PBS, and immediately
macroscopically graded for degeneration via the Collins
scale. Following macroscopic grading, this tissue wasassigned into one of two groups, OA1 (Collins grade 1)
or OA3 (Collins grade 3–4) [8]. In each case, the groups
(OA1 and OA3) were derived from a single knee of a sin-
gle patient. This graded cartilage tissue was then dis-
sected from the remnant joint tissue using a scalpel, with
care taken to avoid underlying bone or tissue from osteo-
phytes. The tissues were divided into two parts, 1st part
for gene expression analysis (RNA isolation and real time
PCR) and 2nd part for histological and immunohisto-
chemical examination.
Isolation of RNA, synthesis of cDNA, and real-time PCR
Total RNA was isolated from OA1 and OA3 grade tis-
sues. The tissues were ground in liquid N2 with a mortar
and pestle, dissolved in Trizol for RNA isolation, per
manufacturer’s instructions, and the quality of the RNA
preparations was monitored by absorbance at 260 and
280 nm (Helios-Gamma, Thermo Spectronic, Rochester,
NY). The RNA was then reverse-transcribed into com-
plementary deoxyribonucleic acid (cDNA) using iScript
reagents from Bio-Rad on a programmable thermal cycler
(PCR-Sprint, Thermo Electron, Milford, MA). 50 ng of
cDNA was amplified in each real-time PCR reaction using
a Bio-Rad iCycler, ABgene reagents (Fisher scientific) and
gene specific primers for HuSVCT2-F GCAGAGCTGTT
GCACACAGAA, HuSVCT2-R CGAGGAGGCCGATGA
CTACTT [9], HuGAPDH-F CATGAGAAGTATGACAA
CAGCCT HuGAPDH-R AGTCCTTCCACGATACCAA
AGT accession number XM_005253678 and Hu18S-F
CAGCCACCCGAGATTGAGCA, Hu18S-F TAGTAG
CGACGGGCGGTGTG accession number NR_003286).
Average of Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and 18S was used as the internal control for
normalization.
Histological and immunohistochemistry examination
Graded cartilage was dissected from the remnant joint
tissue, separated into both healthy and osteoarthritic
samples as previously described, trimmed into approxi-
mately 4 mm × 4 mm squares, embedded within OCT
and snap frozen in liquid nitrogen. Tissue sections were
mounted onto glass slides after sectioning with a cryo-
tome. The three staining approaches utilized included
Hematoxylin and Eosin, Safranin O and Fast Green, and
immunofluorescent staining for SVCT2. For immuno-
staining, sections were fixed with cold acetone for 5 mi-
nutes, blocked in normal donkey serum, incubated with
primary goat anti-SVCT-2 polyclonal antibodies (Santa
Cruz) for 2 hrs at room temperature then washed and
incubated with FITC-labeled goat anti-mouse secondary
antibodies. Sections were counterstained with DAPI and
mounted using aqueous medium. All staining techniques
were performed on both normal and osteoarthritic car-
tilage and slides were qualitatively analyzed.
Table 1 List of donors and ΔΔCt values
Sample no. Sex Age Relative ΔΔCT Ct compared to OA1 grade
1 F 70 −2.11
2 F 72 −6.69
3 M 62 −8.29
4 F 57 −3.01
5 F 56 −4.89
6 F 67 −0.67
7 M 69 −2.11
8 M 70 −1.76
9 F 70 −0.68
10 F 76 −6.37
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All statistical analyses were performed using SAS 9.2.
Statistical significance was assessed using an alpha level
of 0.05 unless otherwise noted. Descriptive statistics in-
cluding the mean, median and standard deviation were
calculated on the mean ΔΔCt for SVCT2 outcome mea-
sures. A one-sample t-test was used to determine whether
the mean ΔΔCt for SVCT2 was significantly different than
zero.
Results and discussion
Numerous studies have suggested that high dietary in-
take of ascorbic acid slows the progression of osteoarth-
ritis, both in guinea pig [10] and human models [11].
This is intuitively understandable as ascorbic acid is re-
quired for regulation of various transcription factors and
collagen synthesis. Like other higher primates, humans
have to rely on dietary intake of vitamin C to satisfy the
body’s daily requirements [4]. High dietary intakes of as-
corbic acid alone, however, cannot account for this ef-
fect, as ascorbic acid is highly water-soluble and cannot
freely diffuse into a cell.
The recent cloning and characterization of two trans-
porters, SVCT1 and SVCT2 [12], have provided an
insight into the mechanisms involved in vitamin C as-
similation from the diet. Uptake of ascorbic acid into the
chondrocyte is achieved primarily through the sodium
dependent vitamin C transporter (SVCT2), a trans-
porter which has been shown previously to concentrateFigure 1 Spaghetti plot showing decrease expression of SVCT2
in OA3 grade samples. Y-axis showing ΔCT values [ΔCT values is
the difference between the CT (cycle threshold) values of the target
gene (SVCT2) and a housekeeping gene] of OA1 and OA3 samples
(n = 29, p < 0.0001). CT levels are inversely proportional to the
amount of target in the sample (i, e the lower the CT level the
greater the amount of target gene expression in the sample).ascorbic acid in guinea pig articular chondrocytes [6] and
primary passaged human chondrocytes [7]. Because of
these essential functions of SVCT2, we sought to investi-
gate the change in the expression of SVCT2 in normal
and osteoarthritic cartilage tissues. Although direct func-
tional changes in the transporters could not be demon-
strated, measurement of their expression levels could
provide some insight into their relative roles during
patho-physiologic changes. Initially, after dissection of
healthy and osteoarthritic cartilage explants tissues, these
tissues were stained and characterized using Safranin O
and Fast Green or Hematoxylin and Eosin (Additional
file 1: Figure S1). These techniques each supported the11 M 70 −4.86
12 F 78 −4.26
13 F 68 −3.22
14 M 63 −3.26
15 M 74 −1.60
16 M 71 −1.19
17 M 78 0.54
18 F 61 −4.22
19 M 61 0.03
20 F 56 −0.54
21 F 55 −2.70
22 F 61 1.96
23 F 61 NA*
24 M 63 −3.35
25 M 63 0.19
26 M 77 −2.49
27 M 73 −0.88
28 F 69 −3.02
29 F 45 −1.24
NA* = No ct values/ amplification in OA3.
ΔΔCT (delta delta Ct) is the difference between control and experimental
samples.It is explained below the Table 2. (ΔΔCT SVCT2: Different between
control (OA1) ΔCT values and OA3 ΔCT values).
Table 2 Descriptive statistics t-test results
Variable Number of
samples
Mean SD Median p-value
ΔΔCT SVCT2 29 −2.5246 2.3304 −2.3000 <0.0001
CT: cycle threshold.
ΔCT values: values are the difference between the CT (cycle threshold) values
of the target gene and a housekeeping gene.
ΔΔCT SVCT2: Different between control (OA1) ΔCT values and OA3 ΔCT values.
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and clarified that we were, in fact, working with appropri-
ately characterized cartilage tissue.
After examining the expression of SVCT2 mRNA
from both OA1 and OA3 osteoarthritic cartilage tissues,
it is clear that at an mRNA level, OA3 osteoarthritic tis-
sue is not well equipped for optimal ascorbic acid transport
(Figure 1, Additional file 2: Figure S2), as our studies re-
vealed a statistically significant median ΔΔCt decrease inFigure 2 Representative immunofluorescence localization of SVCT2 pr
a) 20× and b) 40×. The immunofluorescence analysis was performed u
was anti-goat IgG labeled with FITC. The nuclei were stained with HoeSVCT2 expression of −2.3 (4.93-fold) when OA3 was com-
pared to OA1. A total of 29 patient samples (Table 1) were
used for this analysis, and the mean age was 66.1 years
(Range 45–78, SD = 7.9). Table 2 shows the descriptive sta-
tistics for the ΔΔCt for SVCT2 (p < 0.0001). This finding
was supported by a decrease in the immunoreactivity for
the SVCT2 transporter present on the plasma membrane
of the osteoarthritic chondrocyte (Figure 2, Additional
file 3: Figure S3). There was positive correlation between
mRNA and protein level. OA3 samples showed similar pat-
tern of down-regulation of SVCT2 at both mRNA and
protein level. Down-regulation of SVCT2 expression at
mRNA level leads to less SVCT2 protein synthesis. This
could be the reason for less transporter activity and ultim-
ately less in-take of vitamin C inside the cell.
Though aging has been implicated as a factor contrib-
uting to decreased ascorbic acid uptake in earlier studies,otein in OA1 and OA3 Collins scale grade human cartilage tissue.
sing a polyclonal antibody specific for SVCT2. Secondary antibody
chst dye.
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and 78, it is important to note that aging was not the cause
of our particular findings. As both the OA1 and OA3 tis-
sues used for comparison in this study were derived from
single knees of individual patients, age was not a factor in
the comparisons made between grades. The findings dem-
onstrated by the explant tissue in this study are a direct re-
sult of osteoarthritic cartilage degradation alone.
Furthermore, despite variations in the magnitude of
the decreased expression, this decrease was consistently
present in 86% of patients that we examined. Although
the mechanisms responsible for the down-regulation of
SVCT2 expression in osteoarthritic tissue were not ex-
plored in the present study, this down-regulation sug-
gests alterations in the transcriptional regulation of
SVCT2 by one or more of various factors. These factors
may include oxidative stress, inflammatory factors, growth
factors, growth hormones or a decline in RNA stability
(e.g. by epigenetic factors such as microRNAs), all of
which have been implicated in development of osteo-
arthritis. Recently, various reports have revealed a tran-
scriptional control mechanism for SVCT2 activity by
hormones and intracellular signalling molecules. In these
studies, the SVCT2 expression was altered by epidermal
growth factor and foetal bovine serum in a human
trophoblast cell line [14], and by glucocorticoids [14],
zinc, calcium and phosphate ions [14] in osteoblastic
cells. Inflammatory factors TNF-α and IL-1ß suppressed
the uptake of AA in a dose- and time-dependent manner
in human endothelial cells [15]. Furthermore, this trans-
porter is also regulated by redox modulator in human
lens epithelial cells [16], C2C12 myotubes [17] and
mouse bone marrow stromal cells [18]. Future studies
should seek to delineate the mechanisms of interaction
among the factors mentioned above with particular refer-
ence to their role in vitamin C homeostasis in the human
articular chondrocyte. The outcome of such studies could
help to develop improved and more effective strategies for
management and treatment of osteoarthritis.
Conclusion
The present results demonstrate that the distribution and
overall expression of SVCT2 is significantly altered in de-
generative human articular cartilage grade 3 (OA3) when
compared to human articular cartilage grade 1 (OA1). This
study therefore provides new and previously undocu-
mented evidence regarding the regulation of SVCT2 trans-
porter and its contribution to the osteoarthritis.
Additional files
Additional file 1: Figure S1. (a) Representative Hematoxylin and Eosin
and (b) Safranin O staining of OA1 and OA3 Collins scale grade human
cartilage tissue.Additional file 2: Figure S2. Graph plot showing relative ΔΔCT
compared to OA1 grade human cartilage tissue.
Additional file 3: Figure S3. Quantification of SVCT2 immunofluorescence
of OA1 and OA3 Collins scale grade human cartilage tissue. Values are the
mean ± SEM. **P < 0.0001 by unpaired Student’s t-test.
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